×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Wednesday, March 12th 2025
01pm to 01:45pm (GMT+1)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Modérateur :
Pr Florence Joly

Orateurs :
Dr Margaux Renier
Pr Florence Joly
Dr Paule Augereau

Épisode 1 : Découvrez le programme

 

13:00 Introduction
 
13:02 Cas clinique : Carcinose péritonéale endomètre dMMR
Margaux Renier
 
13:12 Quel traitement aujourd'hui ? place IO en association ?
Florence Joly & Paule Augereau
 
13:22 Place IO seule ou des schémas sans chimio ?
Florence Joly & Paule Augereau
 
13:32 En cas de réponse exceptionnelle, y a t-il encore une place pour la chirurgie ?
Florence Joly & Paule Augereau
 
13:42 Débat/Discussion et réponses aux questions
Florence Joly & Paule Augereau
 

Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !

Épisode 2 Cancer de l'endomètre avancé en rechute précoce :que proposer en 2025
RDV le 26 mars 2025 13h
 
Épisode 3 Cancer de l'endomètre avancé pMMR P53 muté
RDV le 9 avril 2025 13h
 
Épisode 4 Cancer de l'endomètre avancé pMMR NSMP
RDV le 29 avril 2025 13h
 

 

Shooting date : 2025-03-12
Last update : 2025-02-14

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
Honolulu : Tuesday, April 29th 2025 from 02am to 02:45am (GMT+2)
San Francisco : Tuesday, April 29th 2025 from 05am to 05:45am (GMT+2)
New York : Tuesday, April 29th 2025 from 08am to 08:45am (GMT+2)
Buenos Aires : Tuesday, April 29th 2025 from 09am to 09:45am (GMT+2)
Reykjavik : Tuesday, April 29th 2025 from 12pm to 12:45pm (GMT+2)
London / Dublin : Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
Paris / Berlin : Tuesday, April 29th 2025 from 02pm to 02:45pm (GMT+2)
Istanbul : Tuesday, April 29th 2025 from 03pm to 03:45pm (GMT+2)
Moscou / Dubaï : Tuesday, April 29th 2025 from 04pm to 04:45pm (GMT+2)
Bangkok : Tuesday, April 29th 2025 from 07pm to 07:45pm (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 08pm to 08:45pm (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 09pm to 09:45pm (GMT+2)
Sydney : Tuesday, April 29th 2025 from 11pm to 11:45pm (GMT+2)
Wellington : Wednesday, April 30th 2025 from 01am to 01:45am (GMT+2)

Comment prendre en charge un cancer de l'endomètre avancé ?

Cancer de l’endomètre avancé pMMR NSMP (épisode 4)

Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 21st 2023 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, November 21st 2023 from 09am to 10:30am (GMT+1)
New York : Tuesday, November 21st 2023 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, November 21st 2023 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, November 21st 2023 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 21st 2023 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, November 22nd 2023 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, November 22nd 2023 from 05am to 06:30am (GMT+1)

Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

Share
Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, January 31st 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, January 31st 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, January 31st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, January 31st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, January 31st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, January 31st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, February 1st 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, February 1st 2024 from 05am to 06:30am (GMT+1)

KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, February 7th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 05am to 06:30am (GMT+1)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up